Dysfunction of TRPM3 in ME/CFS patients has been shown to affect Ca2+signalling, which has an impact on NK cells regulatory machinery and functions (Cabanas et al. 2018, 2019b). The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.